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ABSTRACT 
Aims: Body fat accumulation is implicated in the development of cardiovascular 
disease (CVD). Our objective was to explore potential associations between 
anthropometric indices and the 10-year CVD incidence in Greek adults without 
previous CVD.  
Methods: During 2001-2, we enrolled 3042 adults without CVD from the general 
population of Attica, Greece. In 2011-2, the 10-year study follow-up was performed, 
recording the CVD incidence in 1958 participants with baseline body mass index 
(BMI) 18.5 kg/m2.  
Results: The study 10-year CVD incidence was 15.8%, exhibiting a gradual increase 
according to the baseline body mass index (BMI) category. Baseline BMI 30 kg/m2 
was related with significantly higher 10-year CVD risk compared to BMI <25 kg/m2, 
even after adjustment for age and other known CVD risk factors. Baseline BMI, waist 
circumference, waist-to-hip ratio, waist-to-height ratio and waist-to-hip-to-height ratio 
were independently associated with the 10-year CVD risk in multi-adjusted models. 
Gender-specific analyses showed that these associations were more evident in men 
compared to women, with baseline BMI exhibiting an independent association with 
the 10-year CVD incidence in men. 
Conclusions: Our results indicate that even simple anthropometric indices exhibit 
independent associations with CVD risk in a representative sample of the Greek 
general population without previous CVD. 
 
Key words: anthropometric indices; cardiovascular disease; body mass index; waist 
circumference; obesity 
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1. INTRODUCTION 
Obesity has reached epidemic proportions and is accompanied by a spectrum 
of deleterious health and socio-economic consequences1. More than one-third of the 
adults in the US is obese (body mass index, BMI 30 kg/m2), with the annual medical 
costs per obese person being $1,429 higher than that of normal-weight individuals2. 
The ATTICA study cohort has also revealed increasing prevalence rates of 
overweight (53% and 31% in men and women, respectively) and obesity (20% and 
15% in men and women, respectively) in the general population of Attica prefecture 
(Greece)3,4.  
In parallel to these obesity trends, cardiovascular disease (CVD) prevalence 
rates have been also increasing, posing a major public health problem with a serious 
economic impact. Indeed, CVD is the leading cause of death globally, accounting for 
more than 17.3 million deaths per year and producing a total cost greater than $316.6 
billion5. Not surprisingly, obesity constitutes one of the key CVD risk factors, with 
adipose tissue distribution playing a vital pathogenetic role6. This strong pathogenetic 
association has raised the question about whether non-invasive, simple 
measures/indices of adiposity, which are easily obtained in everyday clinical practice 
(e.g. BMI, waist circumference and waist-to-hip ratio), can be used to reliably identify 
individuals with high long-term CVD risk. Such simple anthropometric indices have a 
well-established association with increased risk of insulin resistance, type 2 diabetes 
mellitus (T2DM), hyperlipidemia and hypertension7. Hence, anthropometric indices 
are generally considered as CVD risk indicators. However, BMI, which is a crude 
measure of total body adiposity, or other simple anthropometric indices are not 
included in traditional CVD risk models, such as the Framingham risk score (FRS)8,9. 
Moreover, even less evidence exists from large, prospective studies on the exact 
associations between simple anthropometric indices and the long-term CVD risk in 
Mediterranean (South European) populations. 
The objective of the present work was to assess, in the context of the ATTICA 
study10, the potential associations between anthropometric indices obtained at the 
entry/baseline study examination and the 10-year CVD incidence in the study cohort 
consisting of Greek adults from the general population without previous CVD. 
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SUBJECTS, MATERIALS AND METHODS  
2.1 Study design  
The “ATTICA” study is a population-based health and nutrition survey carried 
out in the province of Attica (including 78% urban and 22% rural areas), Greece, 
during 2001-0210. Briefly, the study sampling was designed to enroll only one 
participant per household through a random, multistage process based on the age and 
sex distribution of the Attica region (2001 Census). A total of 4056 adults (18 years) 
were randomly selected, of which 3042 (1514 men; 1528 women) consented to 
participate (75% participation rate). All participants were interviewed/examined by 
trained personnel (cardiologists, other physicians, dieticians and nurses), as per study 
protocol. Individuals with evidence/history of CVD or living in institutions were 
excluded, as previously described10. 
The study was approved by our Institutional Review Board and was carried 
out in accordance with the Declaration of Helsinki (1989) of the World Medical 
Association. All participants were informed about the study aims/procedures and 
provided their consent before any study procedures. 
 
2.2 Baseline measurements  
At baseline, socio-demographic characteristics (age, sex, mean annual income 
and years of education), detailed medical history, dietary and other lifestyle habits, 
(e.g. smoking and physical activities) were recorded. Smoking was defined as 
smoking of at least one cigarette per day during the past year or recent discontinuation 
(during the previous year). Moreover, height, without shoes, was measured to the 
nearest 0.5 cm and body weight to the nearest 100 g, without shoes and with light 
clothing. BMI was calculated as weight (in kilograms, Kg) divided by the height (in 
meters, m) squared. According to the World Health Organization (WHO) obesity 
classification, normal weight, overweight and obesity were defined based on BMI as: 
BMI: 18.5-24.9 kg/m2; 25-29.9 kg/m2; and 30 kg/m2, respectively11. Waist 
circumference was also measured on bare skin during mid-respiration between the 
10th rib and the iliac crest, whilst hip girth was measured at the maximal 
circumference of the buttocks10. Waist-to-hip ratio (WHR), waist-to-height ratio 
(WHtR) and waist-to-hip-to-height ratio (WHHR) was calculated as waist 
circumference divided by hip circumference, or height, or both, respectively.  
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Arterial blood pressure was measured three times at the end of the physical 
examination with the participants at the sitting position for at least 30 minutes. 
Patients with average blood pressure levels ≥140/90 mmHg were classified as having 
hypertension, as those on antihypertensive drugs. Hypercholesterolemia was defined 
as total serum cholesterol levels >200 mg/dl or the use of lipid-lowering agents. 
Diagnosis of Τ2DM was based on the American Diabetes Association (ADA) criteria, 
i.e., fasting blood glucose >125 mg/dL or the use of antidiabetic medication12.  
 
2.3 10-year follow-up 
During 2011-12, the 10-year follow-up of the ATTICA study was performed 
(median follow-up time 8.41 years), as previously described13. Briefly, of the 3042 
participants at baseline, 2583 were found in the follow-up (85% participation rate). 
For the participants who died during the follow-up, the relevant data were obtained 
from their relatives and medical notes/death certificates. The definition of the study 
outcomes was based on the International Classification of Diseases (ICD) 10th 
revision, and CVD data were collected for the development of: (a) myocardial 
infarction, angina pectoris, other identified forms of ischemia; coronary 
revascularization (i.e., coronary artery bypass surgery and percutaneous coronary 
intervention); (b) heart failure of different types and chronic arrhythmias; and (c) 
stroke. Regarding CVD evaluation at follow-up, complete data were obtained from 
2020 participants, of whom 62 participants with baseline BMI <18.5 kg/m2 were 
excluded to avoid reverse causality, yielding a study sample of n=1958 participants 
(men/women: 985/973; 45.413.8 years; with no differences regarding the age-sex 
distribution of this follow-up sample and the baseline; p's >0.80).  
 
2.4 Statistical analysis  
Continuous variables are presented as mean values ± standard deviation (SD) 
and categorical variables as frequencies. The likelihood for CVD development 
(dependent outcome) during the 10-year period, according to the participants’ 
baseline anthropometric indices and the baseline socio-demographic, lifestyle and 
clinical characteristics (independent factors), was estimated using the odds ratio and 
their corresponding 95% confidence intervals (CIs) through multi-adjusted logistic 
regression models. Similarly, the likelihood for CVD development (dependent 
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outcome) during the 10-year period, according to the participants’ baseline body 
weight category and the baseline socio-demographic, lifestyle and clinical 
characteristics (independent factors), was estimated using the odds ratio and their 
corresponding 95% CIs through multiple logistic regression analysis. Moreover, 
survival analyses using Cox Proportional Hazard models were also applied showing 
similar results (data not shown, as the results from the logistic models showed better 
goodness-of-fit). The predictive abilities of the anthropometric indices were ranked by 
calculating the -2log-likelihood of each model (i.e., the lower the better). All reported 
p-values are based on two-sided tests. The SPSS version 21 (Statistical Package for 
Social Sciences, SPSS Inc, Chicago, IL, U.S.A.) software was used for all statistical 
calculations. 
 
2. RESULTS 
2.1 Baseline anthropometric indices and 10-year CVD incidence  
The key baseline characteristics of the study sample (n=1958) are presented in 
Table 1. The overall CVD incidence during the 10-year follow-up period was 15.8% 
(n=310), being significantly higher in men [19.7% (n=194)] than women [11.9% 
(n=116)] (p for gender difference <0.001).   
In the total study sample (n=1958), BMI, waist circumference, WHR, WHtR 
and WHHR were associated with the 10-year CVD incidence in an age-adjusted 
model (Table 2, Model 1), as well as in a model that included age, established CVD 
risk factors (smoking, diabetes, hypertension and hypercholesterolemia), educational 
status (years of school) and physical activity status (Table 2, Model 2). Then, the 
anthropometric indices were analyzed separately for men and women. An 
independent of age association between the 10-year CVD incidence and BMI, waist 
circumference, WHR, WHtR and WHHR was observed in men (Table 2, Model 1). In 
men, the independent association between BMI and the 10-year CVD incidence 
remained even after further adjustment for other known CVD risk factors (i.e., 
smoking, hypertension, hypercholesterolemia, diabetes, educational and physical 
activity status) (Table 2 Model 2). Contrary, in women, while the odds ratios were 
indicative of a positive association, no significant independent associations between 
the baseline anthropometric indices and the 10-year CVD incidence was observed 
(Table 2). Between all investigated anthropometric indices, WHR, WHHR and waist 
circumference had the greater predictive ability (as evaluated with the lower -Log 
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likelihood (L) values) regarding the 10-year CVD risk in the total sample, as well as 
in men and women (Tables 2). 
  
2.2 Baseline BMI categories and 10-year incidence of CVD 
A progressive increase of the 10-year CVD incidence according to the baseline 
body weight status (9.7%, 18.5% and 23.7% for BMI in the normal-weight, 
overweight and obese range, respectively) was observed in the study sample (p for 
trend <0.001). This progressive increase was evident in both men and women (Figure 
1).  
In the total sample, obesity (BMI ≥30 kg/m2) compared to non-obese status 
(BMI <30 kg/m2) or to normal BMI status (BMI: 18.5-24.9 kg/m2), as well as 
overweight (BMI 25-29.9 kg/m2) compared to normal BMI status, were associated 
with significantly increased 10-year CVD incidence independently of age (Table 3, 
Model 1). Additionally, in the total sample the baseline obesity status (BMI ≥30 
kg/m2) compared to normal BMI (18.5-24.9 kg/m2) or to non-obese status (BMI <30 
kg/m2) was independently associated with increased incidence of 10-year CVD events 
in a multivariate model that included age, smoking, hypertension, 
hypercholesterolemia, diabetes, educational and physical activity status (Table 3, 
Model 2). The independent of age increased incidence of 10-year CVD incidence with 
baseline obesity status (BMI ≥30 kg/m2) compared to normal baseline BMI (18.5-24.9 
kg/m2) was evident in men (Table 3, Model 1). In multivariate models, the odds ratios 
of overweight and obesity status compared to normal BMI were indicative of a 
positive association with the 10-year CVD incidence, but without reaching statistical 
significance in either genders (Table 3, Model 2). 
 
3. DISCUSSION 
Herein, we present novel prospective data from the ATTICA study regarding 
the associations between anthropometric indices at the study baseline and the 10-year 
CVD incidence in a representative sample of the Greek general population without 
known CVD. As expected, we observed a gradual increase of the documented 10-year 
CVD incidence according to the baseline BMI class in both genders, Importantly, 
BMI, waist circumference, WHR, WHtR and WHHR were independently associated 
with the 10-year CVD incidence even in multivariate models including other known 
CVD risk factors. 
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These findings are in accord with the reported results from previous cohorts, 
showing an independent association between baseline BMI and long-term CVD 
incidence14. In the Framingham cohort study, which followed patients aged 28-62 
years for a mean of 26 years, the group with increased body weight had higher 
coronary heart disease (CHD) risk compared with the leanest group, independently of 
age, cholesterol, systolic blood pressure, smoking, left ventricular hypertrophy and 
glucose intolerance15. Moreover, our findings are further supported by meta-analysis 
data. Indeed, a meta-analysis that included over one million participants and 37488 
incident CHD cases showed that higher BMI was significantly associated with the 
age-adjusted CHD risk [age-adjusted hazard ratio (HR) in the overweight group 1.20 
(95% CI 1.12–1.29) in women, and 1.22 (95% CI 1.12-1.32) in men; and in the obese 
group: 1.61 (95% CI 1.42-1.82) in women, and 1.60 (95% CI 1.43-1.79) in men, 
compared to the normal weight group]16. Notably, a recent meta-analysis, including 
participants from 189 studies (n=3,951,455) who were never-smokers, did not have 
chronic diseases at recruitment and have survived 5 years, showed that a BMI >25 
kg/m2 is associated with increased CHD mortality [HR 1.42 (95% CI: 1.35-1.49) per 
5 kg/m2 higher BMI]17.  
It is well-established that obesity increases CVD risk indirectly through the 
development of diabetes, hypertension, hyperlipidemia, and metabolic syndrome18. 
Indeed, the prevalence of hypertension is increased in both men and women with BMI 
≥30 kg/m2 compared to normal weight individuals, due to multiple factors, including 
increased systemic vascular resistance, low-grade inflammation, insulin resistance, 
hyperinsulinemia, sympathetic nervous system overactivity and disordered sleep19-21. 
Similarly, dyslipidemia is more frequent among patients with increased body weight, 
with increased fasting triglycerides and low-density lipoprotein cholesterol levels, as 
well as low high-density lipoprotein cholesterol levels. Of note, obesity is further 
associated with the development of the small dense LDL phenotype and postprandial 
hyperlipidemia, leading to accumulation of atherogenic remnants and hepatic 
overproduction of apolipoprotein B-containing lipoproteins22. Moreover, increased 
body weight is associated with the development of insulin resistance, promoting an 
enhanced hepatic flux of free fatty acids to the liver, a mechanism that also links 
obesity, to dyslipidemia and other metabolic syndrome manifestations23. Finally, the 
association of increased body weight with T2DM has also been well-documented, 
with data from the prospective Secondary Manifestations of ARTerial disease 
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(SMART) cohort study showing that patients with increased BMI have higher T2DM 
risk compared to normal-weight subjects, even in the absence of concurrent metabolic 
dysfunction [HR: 2.5 (95% CI 1.5-4.2) for overweight and HR 4.3 (95% CI 2.2-8.6) 
for patients with obesity]24. 
The results of our multi-adjusted analyses, that included other known CVD 
risk factors such as hypertension, hypercholesterolemia, smoking and diabetes, further 
highlight the independent role of increased BMI and other anthropometric indices in 
CVD development. Increased body weight, in addition to the aforementioned indirect 
effects, also affects directly the cardiovascular system. This is potentially mediated 
via structural/functional changes of the heart, ectopic adipose tissue deposition and 
other less well-known obesity-related mechanisms (e.g. detrimental CVD effects of 
various adipokines)6,25,26. Notably, obesity-related heart changes include left 
ventricular chamber dilation, concentric remodeling and concentric left ventricular 
hypertrophy and left atrial enlargement27. These abnormalities have adverse effects on 
diastolic and systolic function, and increase the risk of both heart failure and of atrial 
fibrillation and ventricular arrhythmias28-30. Moreover, obesity accelerates the 
atherosclerotic process, even from a young age. Indeed, autopsy data in young 
subjects (15-34 years) who died from accidental causes have shown that the extent of 
plaques and ulceration in the coronary arteries and abdominal aorta correlates with 
BMI and abdominal fat [Pathobiological Determinants of Atherosclerosis in Youth 
(PDAY) study]31. Furthermore, obesity is the strongest factor linked to non-ST 
elevation myocardial infarction (NSTEMI) events in younger patients32, with data 
showing that as BMI increases NSTEMI and ST-elevation myocardial infarction 
(STEMI) events are presented in patients with lower mean age32,33. Finally, obesity is 
also linked to increased incidence of ischemic stroke, as well as to arrhythmias and 
sudden cardiac death28,34. These effects could also be mediated by the prothrombotic 
(higher levels of plasminogen activator inhibitor-1 antigen and activity, fibrinogen, 
von Willebrand factor, and factor VII) and the proinflammatory state (increased levels 
of C-reactive protein and adipokines/cytokines) observed in obese patients35,36. 
 Our analyses showed that WHR, WHHR, and waist circumference had the 
greater predictive ability between anthropometric indices regarding the 10-year CVD 
risk. These anthropometric indices indicate more precisely the fat distribution 
(visceral vs. subcutaneous) than body weight and BMI. Visceral fat accumulation is 
associated with accumulation of atherosclerotic risk factors, such as hyperlipidemia, 
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hypertension and metabolic syndrome as well as increased risk of T2DM37-40. 
Notably, the measures of fat distribution had similar odds ratios, a finding indicating 
that in clinical practice the measurement of waist circumference, which is easily 
obtained and followed, is not inferior than other more sophisticated measures (WHHR 
or WHtR). Moreover, in the whole sample the measures of fat distribution had 
comparable odds ratios with BMI (a crude measure of adiposity), but in men they 
were not independently associated with CVD risk compared to BMI. This difference 
may indicate that the association of measures of fat distribution with CVD may be 
mediated mainly through the development of comorbidities and accumulation of CVD 
risk factors, whereas total adiposity indices may indicate the presence of additional 
mechanisms that increase CVD risk (discussed above).  
It is important to highlight that we observed stronger correlations of 
anthropometric indices with the 10-year CVD incidence in men compared with 
women. This observation may reflect the effects of abdominal fat distribution, since 
females have a higher proportion of subcutaneous fat and lower visceral fat compared 
to males, leading to different associations with cardiovascular risk factors41. 
Additionally, it may also be in part attributed to the significantly lower CVD events 
that we noted in women, making more difficult any differences in this sample to reach 
statistical significance. Generally, CVD events in women are observed in an older age 
compared with men and this effect may play a role in our study findings. This delayed 
CVD risk in women is at least partly attributed to the protective effects of exposure to 
endogenous oestrogens during the pre-menopausal period of life which appears to 
delay the atherosclerotic process42.   
Overall, the fact that simple anthropometric indices, such as BMI or waist 
circumference, are associated with long-term CVD incidence in our study cohort 
supports the notion that the clinical practice should utilize available indices of total 
and central adiposity as useful markers of increased CVD risk in the general 
population from Mediterranean (South Europe) countries, particularly in men. As 
such, despite their shortcomings as obesity indexes, simple anthropometric indices 
can be easily obtained/followed and, hence, could be useful for CVD risk estimation 
in the general population. Of note, traditional models such as the Framingham risk 
score (FRS) or the Systematic COronary Risk Evaluation (SCORE) risk charts 
include multiple parameters (e.g. cholesterol) but not BMI or waist circumference in 
their equations8,9. Interestingly, a recent analysis of 17791 men and women who 
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participated in the National Research Program 1A (NRP1A) and the Swiss 
Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) 
population survey showed that compared to cholesterol, the use of BMI in the study 
models revealed higher CVD risk at all ages, and could better discriminate persons at 
high and low CVD risk43. Moreover, other authors using electronic health records 
reported that using BMI instead of cholesterol resulted in at least equivalent CVD risk 
estimation44. Thus, the use of simple anthropometric indices as CVD risk indicators 
may aid clinicians to readily and reliably identify subjects at higher risk and reduce 
laboratory testing.  
 
 STRENGTHS AND LIMITATIONS OF THE STUDY  
The present work is the first prospective study assessing the effect of simple 
anthropometric indices on the long-term (10-year) CVD incidence in a large sample 
of the Greek population without previous CVD (reflecting approximately 70% of the 
total Greek population; a population considered, at least to a certain extent, similar to 
those of other Southern/Mediterranean European countries). In addition, the design 
and extended protocol of the ATTICA study allowed the detailed capture of multiple 
factors associated with CVD (socio-demographic, lifestyle, clinical and biological) 
and permitted the analytical evaluation of baseline anthropometric indices on 
multivariate models that included most of the known CVD risk factors. 
Our study has also certain limitations. The baseline anthropometric indices 
were measured once, thus a measurement error may exist. Additionally, 
anthropometric indices may change over time and this cannot be incorporated in the 
presented analyses. However, the study protocol was designed to enrol at baseline 
subjects with rather stable dietary habits and without significant recent body weight 
changes, thus the captured baseline anthropometric indices in this study represent in a 
significant degree the participants’ usual values. The study sample consisted only of 
adults living in the greater Athens metropolitan area, which is mainly an urban region 
and, therefore, cannot entirely represent the Greek population living in more rural 
regions.  
 
4. CONCLUSION 
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Simple anthropometric indices at the baseline/entry ATTICA study examination are 
positively and independently associated with the 10-year CVD incidence in a cohort 
of adults from the general population without previous CVD.  
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FIGURE LEGENDS 
 
Figure 1. The 10-year cardiovascular disease (CVD) incidence in the ATTICA study 
(2001-2 to 2011-2; Attica, Greece) according to the baseline body mass index [BMI 
(kg/m2)] category. 
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Table 1. Anthropometric and clinical characteristics of the study sample (n=1958) at 
the baseline/entry examination of the ATTICA study (Attica, Greece). 
Age (years) 45.413.8 
Gender (men/women) 985/973 
Smoking [n (%)] 1077 (55) 
Education (years of school) 12.23.8 
Body weight (kg) 75.915.2 
Body mass index (kg/m2) 26.54.4 
Waist circumference (cm) 90.814.4 
Waist-to-hip ratio (cm/cm) 0.870.10 
Waist-to-height ratio (cm/cm) 0.540.08 
Waist-to-hip-to-height ratio (cm/cm/m) 0.510.06 
Diabetes [n (%)] 144 (7.4) 
Hypertension [n (%)] 590 (30.1) 
Hypercholesterolemia [n (%)] 843 (40.1) 
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Table 2. Results from multiple logistic regression models*, evaluating the effect of anthropometric (per 1 unit or per 1 SD) indices at baseline in relation to 
the 10-year incidence of cardiovascular disease. 
Variable  
Model 
(-2logL) 
Odds ratio (95% CI) 
all subjects (n=1958) 
Model 
(-2logL) 
Odds ratio (95% CI) 
men (n=985) 
Model 
(-2logL) 
Odds ratio (95% CI) 
women (n=985) 
Body weight Model 1 Per 1 kg 
1.02 (1.01-1.03) 
Per 1 SD 
1.44 (1.24-1.67) 
Model 1 Per 1 kg 
1.02 (1.00-1.03) 
Per 1 SD 
1.25 (1.04-1.50) 
Model 1 Per 1 kg 
1.02 (0.99-1.03) 
Per 1 SD 
1.22 (0.98-1.52) 
 Model 2 
(1252) 
Per 1 kg 
1.02 (1.01-1.03) 
Per 1 SD 
1.35 (1.16-1.58) 
Model 2 
(726) 
Per 1 kg 
1.01 (1.00-1.03) 
Per 1 SD 
1.20 (1.00-1.44) 
Model 2 
(510) 
Per 1 kg 
1.02 (0.99-1.03) 
Per 1 SD 
1.20 (0.96-1.50) 
Body mass 
index 
Model 1 Per 1 kg/m2 
1.06 (1.03-1.09) 
Per 1 SD 
1.29 (1.13-1.47) 
Model 1 Per 1 kg/m2 
1.06 (1.02-1.11) 
Per 1 SD 
1.25 (1.06-1.49) 
Model 1 Per 1 kg/m2 
1.04 (0.99-1.09) 
Per 1 SD 
1.20 (0.97-1.49) 
 Model 2 
(1260) 
Per 1 kg/m2 
1.05 (1.02-1.09) 
Per 1 SD 
1.24 (1.08-1.43) 
Model 2 
(725) 
Per 1 kg/m2 
1.05 (1.00-1.10) 
Per 1 SD 
1.21 (1.00-1.45) 
Model 2 
(511) 
Per 1 kg/m2 
1.03 (0.98-1.08) 
Per 1 SD 
1.16 (0.92-1.47) 
Waist 
circumference 
Model 1 Per 1 cm 
1.03 (1.02-1.04) 
Per 1 SD 
1.43 (1.24-1.66) 
Model 1 Per 1 cm 
1.02 (1.00-1.04) 
Per 1 SD 
1.27 (1.05-1.54) 
Model 1 Per 1 cm 
1.01 (0.99-1.03) 
Per 1 SD 
1.17 (0.93-1.48) 
 Model 2 
(1221) 
Per 1 cm 
1.02 (1.00-1.03) 
Per 1 SD 
1.30 (1.09-1.54) 
Model 2 
(711) 
Per 1 cm 
1.01 (0.99-1.03) 
Per 1 SD 
1.11 (0.90-1.38) 
Model 2 
(489) 
Per 1 cm 
1.01 (0.99-1.03) 
Per 1 SD 
1.14 (0.88-1.48) 
Waist-to-hip 
ratio  
Model 1 Not applicable Per 1 SD 
1.46 (1.27-1.69) 
Model 1 Not applicable Per 1 SD 
1.27 (1.05-1.54) 
Model 1 Not applicable Per 1 SD 
1.13 (0.91-1.40) 
 Model 2 
(1213) 
Not applicable Per 1 SD 
1.33 (1.14-1.55) 
Model 2 
(709) 
Not applicable Per 1 SD 
1.15 (0.94-1.41) 
Model 2 
(485) 
Not applicable Per 1 SD 
1.07 (0.85-1.36) 
Waist-to-height 
ratio 
Model 1 Not applicable Per 1 SD 
1.34 (1.15-1.55) 
Model 1 Not applicable Per 1 SD 
1.26 (1.04-1.53) 
Model 1 Not applicable Per 1 SD 
1.18 (0.92-1.49) 
 Model 2 
(1225) 
Not applicable Per 1 SD 
1.21 (1.03-1.43) 
Model 2 
(711) 
Not applicable Per 1 SD 
1.11 (0.89-1.37) 
Model 2 
(489) 
Not applicable Per 1 SD 
1.13 (0.87-1.46) 
Waist-to-hip-to-
height ratio 
Model 1 
 
Not applicable Per 1 SD 
1.36 (1.17-1.59) 
Model 1 Not applicable Per 1 SD 
1.26 (1.03-1.54) 
Model 1 Not applicable Per 1 SD 
1.13 (0.89-1.44) 
 Model 2 
(1219) 
Not applicable Per 1 SD 
1.24 (1.05-1.46) 
Model 2 
(710) 
Not applicable Per 1 SD 
1.14 (0.92-1.41) 
Model 2 
(485) 
Not applicable Per 1 SD 
1.05 (0.80-1.37) 
Model 1: Adjusted for age, and sex. Model 2: Adjusted for age, cardiovascular disease risk factors (smoking, diabetes, hypertension and 
hypercholesterolemia), educational status (years of school) and physical activity status. SD: standard deviation. *Results of logistic regression models are 
presented as odds ratios and the corresponding confidence interval. 
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Table 3. Results from multiple logistic regression models*, evaluating the associations of the 
body mass index (BMI) category at baseline in relation to the 10-year incidence of 
cardiovascular disease in all subjects (n=1958). 
  BMI <30 
kg/m2 
BMI ≥30 
kg/m2 
BMI <25 
kg/m2 
BMI 25-
29.9 kg/m2 
BMI ≥30  
kg/m2 
All subjects 
 (n=1958) 
Model 1 Ref 1.48 
(1.09-2.01) 
Ref 1.49 
(1.08-2.06) 
1.89 
(1.31-2.72) 
Model 2 Ref 1.42 
(1.03-1.97) 
Ref 1.29 
(0.92-1.81) 
1.68 
(1.14-2.49) 
Men  
(n=985) 
Model 1 Ref 1.46 
(0.99-2.17) 
Ref 1.24 
(0.79-1.94) 
1.70 
(1.03-2.82) 
Model 2 Ref 1.37 
(0.90-2.09) 
Ref 1.11 
(0.69-1.79) 
1.48 
(0.86-2.53) 
Women 
 (n=973) 
Model 1 Ref 1.40 
(0.84-2.31) 
Ref 1.28 
(0.77-2.13) 
1.60 
(0.91-2.80) 
Model 2 Ref 1.36 
(0.80-2.31) 
Ref 1.16 
(0.67-2.00) 
1.49 
(0.81-2.73) 
Model 1: Adjusted for age. Model 2: Adjusted for age, cardiovascular disease 
risk factors (smoking, diabetes, hypertension and hypercholesterolemia), 
educational status (years of school) and physical activity status. SD: standard 
deviation. *Results of logistic regression models are presented as odds ratios and 
the corresponding confidence interval. 
 
 
 
